265 related articles for article (PubMed ID: 16188299)
41. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types.
Klug SJ; Molijn A; Schopp B; Holz B; Iftner A; Quint W; J F Snijders P; Petry KU; Krüger Kjaer S; Munk C; Iftner T
J Med Virol; 2008 Jul; 80(7):1264-74. PubMed ID: 18461626
[TBL] [Abstract][Full Text] [Related]
42. NucliSENS EasyQ HPV v1 test - Testing for oncogenic activity of human papillomaviruses.
Jeantet D; Schwarzmann F; Tromp J; Melchers WJ; van der Wurff AA; Oosterlaken T; Jacobs M; Troesch A
J Clin Virol; 2009 Jul; 45 Suppl 1():S29-37. PubMed ID: 19651366
[TBL] [Abstract][Full Text] [Related]
43. Molecular testing of human papillomavirus in cervical specimens.
Gazzaz FB
Saudi Med J; 2007 Dec; 28(12):1810-8. PubMed ID: 18060207
[TBL] [Abstract][Full Text] [Related]
44. [The morphological characteristics of a papillomavirus infection in the epithelial tissue of the cervix uteri in comparison with the data from the molecular biological identification of specific HPV DNA sequences].
Isakova LM; Ganina KP; Ivanova IM; Vakulenko GA
Tsitol Genet; 1998; 32(1):55-65. PubMed ID: 9695253
[TBL] [Abstract][Full Text] [Related]
45. Detection of human papillomaviruses 16-18 in cervical cells by molecular hybridization: relationship with morphonuclear cell image analyses.
d'Olne D; Kiss R; Coibion M; Verstraete M; Guenier C; de Launoit Y; Verhest A; Pasteels JL; de Martynoff G; Paridaens R
Mod Pathol; 1989 Nov; 2(6):658-65. PubMed ID: 2555818
[TBL] [Abstract][Full Text] [Related]
46. DNA recovery from Hybrid Capture II samples stored in specimen transport medium with denaturing reagent, for the detection of human papillomavirus by PCR.
Rabelo-Santos SH; Levi JE; Derchain SF; Sarian LO; Zeferino LC; Messias S; Moraes DL; Campos EA; Syrjänen KJ
J Virol Methods; 2005 Jun; 126(1-2):197-201. PubMed ID: 15847937
[TBL] [Abstract][Full Text] [Related]
47. Nested PCR with the PGMY09/11 and GP5(+)/6(+) primer sets improves detection of HPV DNA in cervical samples.
Fuessel Haws AL; He Q; Rady PL; Zhang L; Grady J; Hughes TK; Stisser K; Konig R; Tyring SK
J Virol Methods; 2004 Dec; 122(1):87-93. PubMed ID: 15488625
[TBL] [Abstract][Full Text] [Related]
48. [Study for association between high risk human papillomavirus and cervical lesions in the samples from opportunistic screening].
Bian LH; Li Y; Wang XL; Wu XZ; Song L; Liu HT
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):89-91. PubMed ID: 21863625
[TBL] [Abstract][Full Text] [Related]
49. Retrospective and prospective evaluation of the Amplicor HPV test for detection of 13 high-risk human papillomavirus genotypes on 862 clinical samples.
Poljak M; Fujs K; Seme K; Kocjan BJ; Vrtacnik-Bokal E
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Dec; 14(4):147-52. PubMed ID: 16435043
[TBL] [Abstract][Full Text] [Related]
50. Stability of PreservCyt for Hybrid Capture (HC II) HPV test.
Sailors J; Gander R; Saboorian MH; Berkley P; Foster B; Ashfaq R
Diagn Cytopathol; 2005 May; 32(5):260-3. PubMed ID: 15830373
[TBL] [Abstract][Full Text] [Related]
51. Ultrastructural modifications at uterine cervix level induced by human papillomaviruses infections.
Coman N; Ionescu MD; Mişcalencu D
Roum Arch Microbiol Immunol; 1999; 58(1):65-78. PubMed ID: 11845447
[TBL] [Abstract][Full Text] [Related]
52. Quantitative assessment of bladder cancer by nuclear texture analysis using automated high resolution image cytometry.
Gschwendtner A; Hoffmann-Weltin Y; Mikuz G; Mairinger T
Mod Pathol; 1999 Aug; 12(8):806-13. PubMed ID: 10463483
[TBL] [Abstract][Full Text] [Related]
53. [Human papillomavirus detection by the hybrid capture II assay with the liquid cell preservation solution Easyfix].
Leduc F; Bonnière M; Farre I; Staelen P
Ann Biol Clin (Paris); 2004; 62(6):687-90. PubMed ID: 15563427
[TBL] [Abstract][Full Text] [Related]
54. Detection of underlying characteristics of nuclear chromatin patterns of thyroid tumor cells using texture and factor analyses.
Murata S; Mochizuki K; Nakazawa T; Kondo T; Nakamura N; Yamashita H; Urata Y; Ashihara T; Katoh R
Cytometry; 2002 Nov; 49(3):91-5. PubMed ID: 12442308
[TBL] [Abstract][Full Text] [Related]
55. Use of combining in situ hybridization and immunohistochemistry in detecting human papillomavirus on routine sections in cases of diagnostic uncertainty.
Hove MG; Hightower BJ; Graves K
Cent Afr J Med; 2000 Aug; 46(8):217-21. PubMed ID: 11317594
[TBL] [Abstract][Full Text] [Related]
56. Prevalence of cervical and intrauterine human papillomavirus infection in the third trimester in asymptomatic women.
Worda C; Huber A; Hudelist G; Schatten C; Leipold H; Czerwenka K; Eppel W
J Soc Gynecol Investig; 2005 Sep; 12(6):440-4. PubMed ID: 16140235
[TBL] [Abstract][Full Text] [Related]
57. Comparison of type-specific human papillomavirus data from self and clinician directed sampling.
Baldwin S; Santos C; Mendez Brown E; Nuño T; Giuliano A; Davis J; Garcia F
Gynecol Oncol; 2005 May; 97(2):612-7. PubMed ID: 15863168
[TBL] [Abstract][Full Text] [Related]
58. Spectral analysis of cervical cells using the discrete Fourier transform.
Banda-Gamboa H; Ricketts I; Cairns A; Hussein K
Anal Cell Pathol; 1993 Mar; 5(2):85-102. PubMed ID: 8466852
[TBL] [Abstract][Full Text] [Related]
59. Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis.
Boone CW; Kelloff GJ
Cancer Surv; 1998; 32():133-47. PubMed ID: 10489626
[TBL] [Abstract][Full Text] [Related]
60. [The value of the Pap test in the diagnostic approach to HPV infection of the cervix uteri].
Pozzi M; Atlante M; Mariani L; Marandino F; Martino P; Minimo C; Perrone Donnorso R
Minerva Ginecol; 1995; 47(7-8):301-4. PubMed ID: 8559440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
